186 related articles for article (PubMed ID: 9843254)
1. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.
Challa JK; Gillies MC; Penfold PL; Gyory JF; Hunyor AB; Billson FA
Aust N Z J Ophthalmol; 1998 Nov; 26(4):277-81. PubMed ID: 9843254
[TBL] [Abstract][Full Text] [Related]
2. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
3. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
[TBL] [Abstract][Full Text] [Related]
4. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.
Gillies MC; Simpson JM; Billson FA; Luo W; Penfold P; Chua W; Mitchell P; Zhu M; Hunyor AB
Arch Ophthalmol; 2004 Mar; 122(3):336-40. PubMed ID: 15006845
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
Jonas JB; Akkoyun I; Budde WM; Kreissig I; Degenring RF
Arch Ophthalmol; 2004 Feb; 122(2):218-22. PubMed ID: 14769599
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.
Gillies MC; Simpson JM; Luo W; Penfold P; Hunyor AB; Chua W; Mitchell P; Billson F
Arch Ophthalmol; 2003 May; 121(5):667-73. PubMed ID: 12742844
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
[TBL] [Abstract][Full Text] [Related]
9. Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.
Arevalo JF; Garcia RA; Mendoza AJ
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1180-5. PubMed ID: 15906068
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
Ruiz-Moreno JM; Montero JA; Barile S; Zarbin MA
Retina; 2006; 26(6):602-12. PubMed ID: 16829800
[TBL] [Abstract][Full Text] [Related]
12. Exudative macular degeneration and intravitreal triamcinolone. A pilot study.
Penfold PL; Gyory JF; Hunyor AB; Billson FA
Aust N Z J Ophthalmol; 1995 Nov; 23(4):293-8. PubMed ID: 11980075
[TBL] [Abstract][Full Text] [Related]
13. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
[TBL] [Abstract][Full Text] [Related]
14. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
15. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.
Cekiç O; Chang S; Tseng JJ; Barile GR; Del Priore LV; Weissman H; Schiff WM; Ober MD
Retina; 2005; 25(7):851-5. PubMed ID: 16205563
[TBL] [Abstract][Full Text] [Related]
17. The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration.
Roth DB; Kulkarni KM; Feuer WJ
Ophthalmic Surg Lasers Imaging; 2008; 39(1):12-6. PubMed ID: 18254345
[TBL] [Abstract][Full Text] [Related]
18. Indocyanine green-mediated photothrombosis with and without intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration: a pilot study.
Arevalo JF; Mendoza AJ; Fernández CF
Retina; 2005 Sep; 25(6):719-26. PubMed ID: 16141859
[TBL] [Abstract][Full Text] [Related]
19. Triamcinolone and PDT to treat exudative age-related macular degeneration and submacular hemorrhage.
Ruiz-Moreno JM; Montero JA; Barile S
Eur J Ophthalmol; 2006; 16(3):426-34. PubMed ID: 16761245
[TBL] [Abstract][Full Text] [Related]
20. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Chaudhary V; Mao A; Hooper PL; Sheidow TG
Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
